Advanced

EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases

van Assen, S.; Agmon-Levin, N.; Elkayam, O.; Cervera, R.; Doran, M. F.; Dougados, M.; Emery, P.; Geborek, Pierre LU ; Ioannidis, J. P. A. and Jayne, D. R. W., et al. (2011) In Annals of the Rheumatic Diseases 70(3). p.414-422
Abstract
Objectives To develop evidence-based European League Against Rheumatism (EULAR) recommendations for vaccination in patients with autoimmune inflammatory rheumatic diseases (AIIRD). Methods A EULAR task force was composed of experts representing 11 European countries, consisting of eight rheumatologists, four clinical immunologists, one rheumatologist/clinical immunologist, one infectious disease physician, one nephrologist, one paediatrician/rheumatologist and one clinical epidemiologist. Key questions were formulated and the eligible spectrum of AIIRD, immunosuppressive drugs and vaccines were defined in order to perform a systematic literature review. A search was made of Medline from 1966 to October 2009 as well as abstracts from the... (More)
Objectives To develop evidence-based European League Against Rheumatism (EULAR) recommendations for vaccination in patients with autoimmune inflammatory rheumatic diseases (AIIRD). Methods A EULAR task force was composed of experts representing 11 European countries, consisting of eight rheumatologists, four clinical immunologists, one rheumatologist/clinical immunologist, one infectious disease physician, one nephrologist, one paediatrician/rheumatologist and one clinical epidemiologist. Key questions were formulated and the eligible spectrum of AIIRD, immunosuppressive drugs and vaccines were defined in order to perform a systematic literature review. A search was made of Medline from 1966 to October 2009 as well as abstracts from the EULAR meetings of 2008 and 2009 and the American College of Rheumatology (ACR) meetings of 2007 and 2008. Evidence was graded in categories I-IV, the strength of recommendations was graded in categories A-D and Delphi voting was applied to determine the level of agreement between the experts of the task force. Results Eight key questions and 13 recommendations addressing vaccination in patients with AIIRD were formulated. The strength of each recommendation was determined. Delphi voting revealed a very high level of agreement with the recommendations among the experts of the task force. Finally, a research agenda was proposed. Conclusion Recommendations for vaccination in patients with AIIRD based on the currently available evidence and expert opinion were formulated. More research is needed, particularly regarding the incidence of vaccine-preventable infectious diseases and the safety of vaccination in patients with AIIRD. (Less)
Please use this url to cite or link to this publication:
author
, et al. (More)
(Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Annals of the Rheumatic Diseases
volume
70
issue
3
pages
414 - 422
publisher
British Medical Association
external identifiers
  • wos:000286927800003
  • scopus:79951553465
ISSN
1468-2060
DOI
10.1136/ard.2010.137216
language
English
LU publication?
yes
id
fb04de37-ef86-458f-9523-8bda4a7409e0 (old id 1876555)
date added to LUP
2011-04-01 11:21:11
date last changed
2017-11-12 03:39:51
@article{fb04de37-ef86-458f-9523-8bda4a7409e0,
  abstract     = {Objectives To develop evidence-based European League Against Rheumatism (EULAR) recommendations for vaccination in patients with autoimmune inflammatory rheumatic diseases (AIIRD). Methods A EULAR task force was composed of experts representing 11 European countries, consisting of eight rheumatologists, four clinical immunologists, one rheumatologist/clinical immunologist, one infectious disease physician, one nephrologist, one paediatrician/rheumatologist and one clinical epidemiologist. Key questions were formulated and the eligible spectrum of AIIRD, immunosuppressive drugs and vaccines were defined in order to perform a systematic literature review. A search was made of Medline from 1966 to October 2009 as well as abstracts from the EULAR meetings of 2008 and 2009 and the American College of Rheumatology (ACR) meetings of 2007 and 2008. Evidence was graded in categories I-IV, the strength of recommendations was graded in categories A-D and Delphi voting was applied to determine the level of agreement between the experts of the task force. Results Eight key questions and 13 recommendations addressing vaccination in patients with AIIRD were formulated. The strength of each recommendation was determined. Delphi voting revealed a very high level of agreement with the recommendations among the experts of the task force. Finally, a research agenda was proposed. Conclusion Recommendations for vaccination in patients with AIIRD based on the currently available evidence and expert opinion were formulated. More research is needed, particularly regarding the incidence of vaccine-preventable infectious diseases and the safety of vaccination in patients with AIIRD.},
  author       = {van Assen, S. and Agmon-Levin, N. and Elkayam, O. and Cervera, R. and Doran, M. F. and Dougados, M. and Emery, P. and Geborek, Pierre and Ioannidis, J. P. A. and Jayne, D. R. W. and Kallenberg, C. G. M. and Mueller-Ladner, U. and Shoenfeld, Y. and Stojanovich, L. and Valesini, G. and Wulffraat, N. M. and Bijl, M.},
  issn         = {1468-2060},
  language     = {eng},
  number       = {3},
  pages        = {414--422},
  publisher    = {British Medical Association},
  series       = {Annals of the Rheumatic Diseases},
  title        = {EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases},
  url          = {http://dx.doi.org/10.1136/ard.2010.137216},
  volume       = {70},
  year         = {2011},
}